Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
TKNO - Alpha Teknova Inc - Stock Price Chart
TickerTKNO [NASD]
CompanyAlpha Teknova Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap332.59MEPS (ttm)-0.93
P/E-EPS this Y52.16%
Forward P/E-EPS next Y23.42%
PEG-EPS past 5Y-113.92%
P/S9.52EPS next 5Y-
P/B3.23EPS Q/Q48.10%
Dividend-Sales Q/Q-16.60%
Insider Own80.07%Inst Own10.99%
Insider Trans40.11%Inst Trans-
Short Float2.67%EarningsAug 13/a
Analyst Recom1.80Target Price5.50
Avg Volume622.94K52W Range1.15 - 5.47
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Telegraph Hill Partners IV, L.10% OwnerJul 12 '24Buy1.2412,096,77314,999,99911,126,929Jul 16 09:13 PM
Lowell MatthewChief Financial OfficerJul 12 '24Buy1.2440,32249,999128,376Jul 16 05:15 PM
Gunstream StephenPresident and CEOJul 12 '24Buy1.2480,645100,000243,497Jul 16 05:15 PM
Gelhaus KenChief Commercial OfficerNov 30 '23Buy1.733,5876,22022,924Dec 01 05:44 PM
LNSR - LENSAR Inc - Stock Price Chart
TickerLNSR [NASD]
CompanyLENSAR Inc
CountryUSA
IndustryMedical Devices
Market Cap64.20MEPS (ttm)-1.11
P/E-EPS this Y-16.23%
Forward P/E-EPS next Y46.67%
PEG-EPS past 5Y0.14%
P/S1.42EPS next 5Y-
P/B2.70EPS Q/Q2.39%
Dividend-Sales Q/Q5.19%
Insider Own21.41%Inst Own41.84%
Insider Trans0.22%Inst Trans0.44%
Short Float0.74%EarningsAug 08/b
Analyst Recom1.00Target Price8.00
Avg Volume25.33K52W Range1.80 - 5.60
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winer Gary MDirectorSep 03 '24Buy4.506853,08280,840Sep 06 09:00 AM
Winer Gary MDirectorAug 28 '24Buy4.451,0004,45080,155Aug 29 06:05 AM
Winer Gary MDirectorAug 26 '24Buy4.588023,67378,655Aug 29 06:05 AM
Winer Gary MDirectorAug 27 '24Buy4.505002,25079,155Aug 29 06:05 AM
Winer Gary MDirectorAug 21 '24Buy4.355002,17677,851Aug 23 06:52 PM
AREB - American Rebel Holdings Inc - Stock Price Chart
TickerAREB [NASD]
CompanyAmerican Rebel Holdings Inc
CountryUSA
IndustryFootwear & Accessories
Market Cap3.05MEPS (ttm)-18.55
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y68.82%
P/S0.20EPS next 5Y-
P/B0.73EPS Q/Q-2.78%
Dividend-Sales Q/Q-11.31%
Insider Own1.25%Inst Own2.46%
Insider Trans0.00%Inst Trans-
Short Float1.80%EarningsAug 20/b
Analyst Recom1.00Target Price18.00
Avg Volume354.05K52W Range1.90 - 9.27
Oct-10-24 09:26AM American Rebel CEO and American Rebel to be Featured at NHRA FallNationals Pre-Stage Fan Fest October 10 in Waxahachie, Texas (GlobeNewswire)
Oct-03-24 08:00AM American Rebel Holdings, Inc. Ships Initial Order of 12oz and 16oz Tall Boy cans of American Rebel Light Beer to leading Tennessee Distributor, Best Brands Incorporated (GlobeNewswire) -30.79%
Oct-02-24 09:15AM American Rebel Holdings, Inc. Ships Re-Stocking Order from Kansas' Standard Beverage for American Rebel Light Beer (GlobeNewswire) -47.72%
08:00AM AMERICAN REBEL HOLDINGS, INC. (NASDAQ: AREB) ANNOUNCES EFFECTIVENESS OF 1-FOR-9 REVERSE STOCK SPLIT AT THE OPEN OF TRADING ON OCTOBER 2, 2024 (GlobeNewswire)
Oct-01-24 08:05AM American Rebel Light Beer Announces Initial Shipment of 12oz and 16oz cans to Dichello Distributors, Inc., the largest privately owned Anheuser-Busch distributorship in Connecticut. (GlobeNewswire)
Sep-27-24 04:45PM AMERICAN REBEL ANNOUNCES 1-FOR-9 REVERSE STOCK SPLIT (GlobeNewswire) +64.95%
08:00AM American Rebel Light Beer is Primary Sponsor of Tony Stewart Racing Team's SRT Hellcat Funny Car driven by Matt Hagan at the NHRA Midwest Nationals in St. Louis (GlobeNewswire)
Sep-09-24 09:03AM American Rebel Light Beer Completes Initial Production Run of 12oz and Tall Boy 16oz Cans (GlobeNewswire) +8.73%
Sep-05-24 08:00AM American Rebel to Participate in the HC Wainwright Global Investment Conference (GlobeNewswire)
Aug-29-24 09:42AM Missouri Eagle, Proud Distributor of Quality Anheuser-Busch Beers, to Distribute American Rebel Light in Southwest Missouri (GlobeNewswire)
American Rebel Holdings, Inc. engages in the design and marketing of branded safes, and personal security and self-defense products. It also designs and manufactures branded apparel and accessories. The company was founded on December 15, 2014 and is headquartered in Brentwood, TN.
QMCO - Quantum Corp - Stock Price Chart
TickerQMCO [NASD]
CompanyQuantum Corp
CountryUSA
IndustryComputer Hardware
Market Cap18.44MEPS (ttm)-11.06
P/E-EPS this Y62.07%
Forward P/E-EPS next Y45.45%
PEG-EPS past 5Y18.45%
P/S0.06EPS next 5Y20.00%
P/B-EPS Q/Q-92.39%
Dividend-Sales Q/Q-22.27%
Insider Own13.97%Inst Own54.93%
Insider Trans0.00%Inst Trans0.70%
Short Float5.53%EarningsAug 13/a
Analyst Recom3.00Target Price7.50
Avg Volume40.04K52W Range2.22 - 18.00
Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual and cloud environments. Its product portfolio includes Myriad All-Flash File and Object Storage Software, StorNext Hybrid Flash and Disk File Storage Software, and Unified Surveillance Platform Software. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cabrera Brian ESVP Chief Admin Ofcr & SecyNov 02 '23Sale0.475,5432,586221,887Nov 03 04:38 PM
GANX - Gain Therapeutics Inc - Stock Price Chart
TickerGANX [NASD]
CompanyGain Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap60.02MEPS (ttm)-1.31
P/E-EPS this Y39.42%
Forward P/E-EPS next Y12.16%
PEG-EPS past 5Y-79.01%
P/S-EPS next 5Y-
P/B5.02EPS Q/Q31.71%
Dividend-Sales Q/Q-
Insider Own5.09%Inst Own11.89%
Insider Trans6.68%Inst Trans18.95%
Short Float2.70%EarningsAug 08/b
Analyst Recom1.00Target Price7.40
Avg Volume347.53K52W Range0.89 - 5.33
Oct-09-24 08:30AM Gain Therapeutics to Present at Michael J. Fox Foundation's 16th Annual Parkinson's Disease Therapeutics Conference (GlobeNewswire)
Oct-07-24 07:00AM Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024 (GlobeNewswire) +17.31%
Oct-03-24 07:00AM Gain Therapeutics to Participate at Upcoming Investor Conferences (GlobeNewswire)
Sep-30-24 07:00AM Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson's Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers (GlobeNewswire) -10.55%
Sep-26-24 07:00AM Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease (GlobeNewswire)
Sep-19-24 07:00AM Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson's Disease Models Including Two Late-Breakers at Neuroscience 2024 (GlobeNewswire)
Sep-03-24 07:00AM Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-30-24 04:52AM Gain Therapeutics reports positive data from Phase I Parkinsons treatment trial (Clinical Trials Arena)
Aug-29-24 07:30AM Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease (GlobeNewswire) -20.15%
Aug-08-24 07:30AM Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mack GeneCFO and Interim CEOAug 09 '24Buy1.0114,40014,54414,400Aug 12 05:23 PM
Islam KhalidExecutive ChairmanAug 09 '24Buy1.0050,00049,94050,000Aug 12 05:23 PM
RICHMAN ERIC IDirectorJul 01 '24Buy1.2217,00020,670289,629Jul 01 05:00 PM
Riley Jeffrey ScottDirectorMar 28 '24Buy3.8630,000115,77030,000Apr 01 04:01 PM
Alder MatthiasChief Executive OfficerDec 21 '23Sale2.462065075,286Dec 22 04:17 PM
DOGZ - Dogness (International) Corp - Stock Price Chart
TickerDOGZ [NASD]
CompanyDogness (International) Corp
CountryChina
IndustryLeisure
Market Cap580.74MEPS (ttm)-0.41
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S41.90EPS next 5Y-
P/B6.42EPS Q/Q-300.13%
Dividend-Sales Q/Q-35.81%
Insider Own86.95%Inst Own0.12%
Insider Trans0.00%Inst Trans-10.01%
Short Float14.45%Earnings-
Analyst Recom-Target Price-
Avg Volume145.89K52W Range2.79 - 41.90
Dogness (International) Corp. engages in the design and manufacture of pet products, including leashes, and smart products. Its products include leashes, lanyards, ribbon, collars, harnesses ornaments, and specialty products for cats and dogs. The firm produces the products in Classic, Elegance, Luxury, LED, Holiday, Special Function, and Cat series. The company was founded by Shilong Chen in 2003 and is headquartered in Dongguan, China.
CNTB - Connect Biopharma Holdings Ltd ADR - Stock Price Chart
TickerCNTB [NASD]
CompanyConnect Biopharma Holdings Ltd ADR
CountryChina
IndustryBiotechnology
Market Cap77.35MEPS (ttm)-
P/E-EPS this Y81.87%
Forward P/E-EPS next Y100.00%
PEG-EPS past 5Y-39.81%
P/S-EPS next 5Y-
P/B0.70EPS Q/Q113.37%
Dividend-Sales Q/Q-
Insider Own3.62%Inst Own5.39%
Insider Trans0.00%Inst Trans7.88%
Short Float0.07%EarningsSep 05/a
Analyst Recom1.00Target Price8.00
Avg Volume28.96K52W Range0.68 - 2.84
Sep-10-24 08:00AM Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024 (GlobeNewswire)
Sep-05-24 04:05PM Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update (GlobeNewswire) -7.76% +5.05%
Jul-01-24 08:00AM Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum (GlobeNewswire) -5.26%
Jun-12-24 06:03PM Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.08%
04:15PM Connect Biopharma Announces New Leadership and Chair of the Board of Directors (GlobeNewswire)
May-22-24 04:05PM Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma (GlobeNewswire) -5.08% +7.14%
May-07-24 06:30AM Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma (GlobeNewswire)
May-02-24 02:33PM Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management (Newsfile) +8.39%
Apr-16-24 04:05PM Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -10.40%
Mar-19-24 08:30AM Connect Biopharma to Participate in H.C. Wainwright 2 Annual Autoimmune & Inflammatory Disease Virtual Conference (GlobeNewswire)
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CLSK - Cleanspark Inc - Stock Price Chart
TickerCLSK [NASD, RUT]
CompanyCleanspark Inc
CountryUSA
IndustryCapital Markets
Market Cap2.74BEPS (ttm)-0.78
P/E-EPS this Y-388.69%
Forward P/E89.84EPS next Y125.08%
PEG-EPS past 5Y37.20%
P/S8.00EPS next 5Y-
P/B1.82EPS Q/Q-734.57%
Dividend-Sales Q/Q128.69%
Insider Own3.42%Inst Own41.38%
Insider Trans-0.33%Inst Trans3.01%
Short Float18.91%EarningsAug 09/a
Analyst Recom1.43Target Price22.64
Avg Volume23.74M52W Range3.46 - 24.72
CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Monnig TaylorChief Technology OfficerSep 27 '24Sale10.441,35014,094209,652Sep 27 04:30 PM
Monnig TaylorOfficerSep 27 '24Proposed Sale10.441,35014,094Sep 27 04:30 PM
Vecchiarelli Gary AnthonyChief Financial OfficerSep 12 '24Option Exercise0.0040,0000594,391Sep 13 04:44 PM
Schultz S. MatthewExecutive ChairmanSep 12 '24Option Exercise0.00405,00002,703,975Sep 13 04:43 PM
Bradford ZacharyCEO and PresidentSep 12 '24Option Exercise0.00450,00003,245,863Sep 13 04:42 PM
TENX - Tenax Therapeutics Inc - Stock Price Chart
TickerTENX [NASD]
CompanyTenax Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.92MEPS (ttm)-22.37
P/E-EPS this Y78.30%
Forward P/E-EPS next Y32.41%
PEG-EPS past 5Y70.74%
P/S-EPS next 5Y-
P/B0.84EPS Q/Q54.37%
Dividend-Sales Q/Q-
Insider Own12.50%Inst Own31.09%
Insider Trans0.00%Inst Trans-
Short Float0.98%EarningsAug 13/a
Analyst Recom1.00Target Price23.00
Avg Volume497.33K52W Range2.77 - 61.20
TodayInitiated Guggenheim Buy $16
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.
DGLY - Digital Ally Inc. - Stock Price Chart
TickerDGLY [NASD]
CompanyDigital Ally Inc.
CountryUSA
IndustryInternet Content & Information
Market Cap4.40MEPS (ttm)-7.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y24.86%
P/S0.19EPS next 5Y20.00%
P/B1.72EPS Q/Q42.24%
Dividend-Sales Q/Q-32.17%
Insider Own7.48%Inst Own14.53%
Insider Trans0.00%Inst Trans-
Short Float9.58%EarningsAug 16/a
Analyst Recom1.00Target Price11.00
Avg Volume1.72M52W Range0.84 - 3.29
Digital Ally, Inc. engages in the design, manufacture, and sale of digital audio, video recording, and speed detection devices. It operates through the following segments: Video Solutions, Revenue Cycle Management, and Entertainment. The Video Solutions segment includes video recording products and services for law enforcement and commercial customers and the sale of Shield disinfectant and personal protective products. The Revenue Cycle Management Segment consists of medical billing subsidiaries. The Entertainment segment focuses on ticketing services provided through TicketSmarter and its online platform, TicketSmarter.com. The company was founded on December 13, 2000 and is headquartered in Lenexa, KS.
1234567891020